Display options
Share it on

Int Urogynecol J. 2016 Dec;27(12):1785-1795. doi: 10.1007/s00192-016-2993-9. Epub 2016 Mar 12.

Prevention of pelvic floor disorders: international urogynecological association research and development committee opinion.

International urogynecology journal

Tony Bazi, Satoru Takahashi, Sharif Ismail, Kari Bø, Alejandra M Ruiz-Zapata, Jonathan Duckett, Dorothy Kammerer-Doak

Affiliations

  1. Department of Obstetrics and Gynecology, Faculty of Medicine, American University of Beirut Medical Center, PO Box 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon. [email protected].
  2. Department of Urology, Nihon University School of Medicine, Tokyo, Japan.
  3. Brighton and Sussex Medical School, Brighton and Sussex University Hospitals NHS Trust, Brighton, England, UK.
  4. Norwegian School of Sport Sciences, Oslo, Norway.
  5. Department of Obstetrics and Gynecology, Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  6. Directorate of Women's Health, Medway NHS Foundation Trust, Gillingham, UK.
  7. Women's Pelvic Specialty Care of New Mexico, University of New Mexico Hospital, Albuquerque, NM, USA.

PMID: 26971276 DOI: 10.1007/s00192-016-2993-9

Abstract

INTRODUCTION AND HYPOTHESIS: Pelvic floor disorders (PFD), including urinary incontinence, anal incontinence, and pelvic organ prolapse, are common and have a negative effect on the quality of life of women. Treatment is associated with morbidity and may not be totally satisfactory. Prevention of PFDs, when possible, should be a primary goal. The purpose of this paper is to summarise the current literature and give an evidence-based review of the prevention of PFDs METHODS: A working subcommittee from the International Urogynecological Association (IUGA) Research and Development (R&D) Committee was formed. An initial document addressing the prevention of PFDs was drafted, based on a review of the English-language literature. After evaluation by the entire IUGA R&D Committee, revisions were made. The final document represents the IUGA R&D Committee Opinion on the prevention of PFDs.

RESULTS: This R&D Committee Opinion reviews the literature on the prevention of PFDs and summarises the findings with evidence-based recommendations.

CONCLUSIONS: Pelvic floor disorders have a long latency, and may go through periods of remission, thus making causality difficult to confirm. Nevertheless, prevention strategies targeting modifiable risk factors should be incorporated into clinical practice before the absence of symptomatology.

Keywords: IUGA Research and Development Committee Opinion; Obstetric anal sphincter injuries; Pelvic floor disorders; Pelvic organ prolapse; Prevention; Urinary incontinence

References

  1. Obstet Gynecol. 2014 Jun;123(6):1201-6 - PubMed
  2. Am J Obstet Gynecol. 2007 Aug;197(2):167.e1-5 - PubMed
  3. Obstet Gynecol. 2012 May;119(5):950-7 - PubMed
  4. BJOG. 2012 Apr;119(5):522-6 - PubMed
  5. BJOG. 2010 Nov;117(12 ):1485-92 - PubMed
  6. BJOG. 2012 Oct;119(11):1361-9 - PubMed
  7. Aust N Z J Obstet Gynaecol. 2007 Dec;47(6):491-5 - PubMed
  8. Br J Obstet Gynaecol. 1980 May;87(5):408-12 - PubMed
  9. Int Urogynecol J. 2012 Apr;23(4):395-401 - PubMed
  10. Obstet Gynecol. 2000 Sep;96(3):446-51 - PubMed
  11. J Sports Sci. 2014;32(12):1176-85 - PubMed
  12. J Urol. 2015 May;193(5):1572-80 - PubMed
  13. Eur Urol. 2000 Jan;37(1):30-5 - PubMed
  14. Int Urogynecol J. 2015 Oct;26(10):1429-36 - PubMed
  15. Acta Obstet Gynecol Scand. 2015 Apr;94(4):347-51 - PubMed
  16. Neurourol Urodyn. 2004;23 (3):204-10 - PubMed
  17. Am J Obstet Gynecol. 2014 Jan;210(1):59.e1-6 - PubMed
  18. Acta Obstet Gynecol Scand. 2001 Mar;80(3):229-34 - PubMed
  19. Int Urogynecol J. 2014 Jun;25(6):775-82 - PubMed
  20. Int J Epidemiol. 2006 Feb;35(1):93-9 - PubMed
  21. BJOG. 2015 Aug;122(9):1157-65 - PubMed
  22. Obstet Gynecol. 2006 Jan;107(1):144-9 - PubMed
  23. BJOG. 2013 Nov;120(12):1548-55 - PubMed
  24. BJOG. 2000 Dec;107(12):1460-70 - PubMed
  25. Neurourol Urodyn. 2014 Nov;33(8):1229-34 - PubMed
  26. Cochrane Database Syst Rev. 2013 Dec 08;(12):CD002866 - PubMed
  27. BMC Pregnancy Childbirth. 2015 Oct 09;15:252 - PubMed
  28. Obstet Gynecol. 1997 Nov;90(5):718-22 - PubMed
  29. Curr Opin Obstet Gynecol. 2015 Oct;27(5):380-4 - PubMed
  30. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Feb;20(2):193-9 - PubMed
  31. Obstet Gynecol. 2010 Apr;115(4):795-803 - PubMed
  32. Obstet Gynecol. 2009 Jan;113(1):81-8 - PubMed
  33. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD005123 - PubMed
  34. Am J Obstet Gynecol. 2012 Oct;207(4):303.e1-7 - PubMed
  35. J Urol. 2011 May;185(5):1775-80 - PubMed
  36. J Urol. 2010 Oct;184(4):1394-401 - PubMed
  37. BJU Int. 2003 Jul;92(1):69-77 - PubMed
  38. BJOG. 2013 Jan;120(2):144-51 - PubMed
  39. Int J Gynaecol Obstet. 2003 Sep;82(3):327-38 - PubMed
  40. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(1):15-7 - PubMed
  41. Cochrane Database Syst Rev. 2015 Oct 09;(10):CD009124 - PubMed
  42. Int Urogynecol J. 2014 Nov;25(11):1449-52 - PubMed
  43. Obstet Gynecol. 2006 Feb;107(2 Pt 1):305-9 - PubMed
  44. Ultrasound Obstet Gynecol. 2012 Apr;39(4):372-83 - PubMed
  45. Int Urogynecol J. 2014 Nov;25(11):1547-53 - PubMed
  46. BJOG. 2012 May;119(6):724-30 - PubMed
  47. Obstet Gynecol. 2011 Oct;118(4):777-84 - PubMed
  48. Obes Rev. 2014 Jul;15(7):610-7 - PubMed
  49. Cochrane Database Syst Rev. 2011 Dec 07;(12):CD003882 - PubMed
  50. Female Pelvic Med Reconstr Surg. 2013 Mar-Apr;19(2):110-8 - PubMed
  51. Cochrane Database Syst Rev. 2009 Oct 07;(4):CD006067 - PubMed
  52. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD000081 - PubMed
  53. Cochrane Database Syst Rev. 2012 Oct 17;10:CD007471 - PubMed
  54. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jun;17(4):340-5 - PubMed
  55. Urology. 2012 Jul;80(1):48-54 - PubMed
  56. BJOG. 2013 Jan;120(2):152-60 - PubMed
  57. Int Urogynecol J. 2015 Aug;26(8):1179-84 - PubMed
  58. Urology. 2009 Jun;73(6):1203-9 - PubMed
  59. Ultrasound Obstet Gynecol. 2015 Oct;46(4):487-95 - PubMed
  60. Sports Med. 2004;34(7):451-64 - PubMed
  61. PLoS One. 2014 Sep 09;9(9):e107053 - PubMed
  62. Int Urogynecol J. 2015 Nov;26(11):1559-73 - PubMed
  63. BJOG. 2015 May;122(6):816-24 - PubMed
  64. Obstet Gynecol. 2009 Nov;114(5):989-98 - PubMed
  65. Age Ageing. 2009 May;38(3):333-8; discussion 251 - PubMed
  66. Cochrane Database Syst Rev. 2010 Nov 10;(11):CD005455 - PubMed
  67. Obstet Gynecol. 2013 Dec;122(6):1231-8 - PubMed
  68. BJOG. 2014 Apr;121(5):604-9 - PubMed
  69. J Urol. 2004 Mar;171(3):1165-71 - PubMed
  70. Cochrane Database Syst Rev. 2011 Dec 07;(12):CD006672 - PubMed
  71. Birth. 2007 Dec;34(4):282-90 - PubMed
  72. Semin Perinatol. 2012 Oct;36(5):315-23 - PubMed
  73. Neurourol Urodyn. 2014 Jan;33(1):67-71 - PubMed
  74. N Engl J Med. 2003 Mar 6;348(10):900-7 - PubMed
  75. BJOG. 2003 Mar;110(3):247-54 - PubMed
  76. JAMA. 2002 Apr 10;287(14):1822-31 - PubMed
  77. Am J Gastroenterol. 2013 Jan;108(1):113-9 - PubMed
  78. Annu Rev Biomed Eng. 2009;11:163-76 - PubMed
  79. BJOG. 2011 Jul;118(8):1001-7 - PubMed
  80. Int Urogynecol J. 2014 Oct;25(10):1411-8 - PubMed
  81. Obstet Gynecol. 2002 Dec;100(6):1230-8 - PubMed
  82. Neurourol Urodyn. 2014 Sep;33(7):1086-91 - PubMed
  83. Neurourol Urodyn. 2015 Apr;34(4):356-61 - PubMed
  84. Am J Obstet Gynecol. 2004 Sep;191(3):917-27 - PubMed
  85. BJOG. 2008 Jan;115(2):234-8 - PubMed
  86. Menopause. 2013 Apr;20(4):428-36 - PubMed
  87. Int J Gynaecol Obstet. 2011 Dec;115(3):256-9 - PubMed

MeSH terms

Publication Types